BRIEF published on 05/14/2024 at 22:40, 2 years 5 months ago First 5 Network Challenges California's Proposed State Budget Cuts California Budget Cuts Child Services First 5 Network Medi-Cal Eligibility Early Childhood Education
BRIEF published on 05/14/2024 at 22:40, 2 years 5 months ago Les cinq premiers réseaux remettent en question les réductions budgétaires proposées par l'État de Californie Coupes Budgétaires En Californie Services À L'enfance Premier Réseau 5 Éligibilité Médicale L'éducation De La Petite Enfance
BRIEF published on 05/14/2024 at 22:26, 2 years 5 months ago Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
BRIEF published on 05/14/2024 at 22:26, 2 years 5 months ago Bausch Health annonce des mises à jour sur le litige Norwich XIFAXAN et une nouvelle soumission à la FDA XIFAXAN Bausch Santé Contentieux Des Brevets Norwich Pharmaceutique Soumission À La FDA
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago Sonnet BioTherapeutics Announces Fiscal Year 2024 Q2 Results and Business Updates Financial Results Clinical Trials Oncology Biopharmaceuticals Sonnet BioTherapeutics
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago Sonnet BioTherapeutics annonce ses résultats du deuxième trimestre de l'exercice 2024 et des mises à jour sur ses activités Résultats Financiers Essais Cliniques Oncologie Sonnet BioTherapeutics Produits Biopharmaceutiques
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
BRIEF published on 05/14/2024 at 22:15, 2 years 5 months ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF published on 05/14/2024 at 22:15, 2 years 5 months ago GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025 Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
Published on 10/23/2026 at 02:20, 5 hours 31 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 8 hours 21 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 9 hours 21 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 15 hours 51 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 17 hours 21 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 07:00, 51 minutes ago EQS-Adhoc: BB Biotech AG publishes its interim report
Published on 10/23/2026 at 07:00, 51 minutes ago ATOSS Software SE: Revenue growth and high profitability in the third quarter put ATOSS on track for another record year
Published on 10/23/2026 at 07:00, 51 minutes ago BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment
Published on 10/23/2026 at 06:45, 1 hour 6 minutes ago GURIT REPORTS SOLID THIRD-QUARTER PERFORMANCE AND REITERATES FULL-YEAR GUIDANCE
Published on 10/23/2026 at 06:30, 1 hour 21 minutes ago HBM Healthcare Investments publishes Half-Year Report as at 30 September 2026 with key figures for the first six months of the 2026/2027 financial year
Published on 10/23/2026 at 07:00, 51 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 13 hours 51 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 13 hours 51 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 13 hours 51 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
